National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16–18, 2000
… Institutes of Health Consensus Development Panel - …, 2001 - publications.aap.org
Objective. To provide health care providers, patients, and the general public with a
responsible assessment of currently available data regarding screening for and
management of phenylketonuria (PKU). Participants. A nonfederal, nonadvocate, 14-
member panel representing the fields of pediatrics, genetics, human development, public
policy, nursing, and molecular physiology and including patient representatives. In addition,
19 experts in pediatrics, medical genetics, psychology, pediatric neurology, biochemical and …
responsible assessment of currently available data regarding screening for and
management of phenylketonuria (PKU). Participants. A nonfederal, nonadvocate, 14-
member panel representing the fields of pediatrics, genetics, human development, public
policy, nursing, and molecular physiology and including patient representatives. In addition,
19 experts in pediatrics, medical genetics, psychology, pediatric neurology, biochemical and …
